Three independent discounted-cash-flow-style models value Thermo Fisher Scientific Inc. every trading day. 0 of 3 currently price TMO above its market price.
| Free Cash Flow model | $115.61 |
| Excess Profit model | $97.82 |
| Residual Earnings model | $87.95 |
| Dividend Discount model | $78.68 |
| Piotroski F-Score | 6 / 9 |
| Return on invested capital | +6.9% |
| Net debt / EBITDA | 2.6× |
| Gross margin | +40.9% |
| Revenue CAGR | -0.3% |
| Cash conversion | 1.2× |
| Dividend yield | +0.3% |
| Buyback yield | +1.2% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open TMO in StockKitty